spontaneous diuresis in combination with furosemide stress test (FST) as a prognosis marker for successful discontinuitation of renal replacement therapy : A prospective observational trial

spontaneous diuresis in combination with furosemide stress test (FST) as a prognosis marker for successful discontinuitation of renal replacement therapy : A prospective observational trial - FST-SD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030560

Enrollment

100

Registered

2022-11-18

Start date

2023-01-20

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N17.93

Interventions

Group 1: spontaneous daily diuresis >= 400ml and FST >= 200ml/2h Group 2: spontaneous daily diuresis >= 400ml and FST < 200ml/2h

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: acute kidney injury requirement of renal replacement therapy increased spontaneous daily diuresis of at least 400 ml

Exclusion criteria

Exclusion criteria: Age lower 18 years chronic renal failure requiring dialysis/CKD5 women during pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Requirement of RRT again within the first 7 days after discontinuation of RRT	—

Secondary

Measure	Time frame
Mortality and renal function on the day 28 and 90 Prognostic value of urine biomarkers for successful stopped RRT	—

Countries

Germany

Contacts

Public ContactLorenz Weidhase

Universitätsklinikum Leipzig, DIND, Interdisziplinäre Internistische Intensivmedizin

lorenz.weidhase@medizin.uni-leipzig.de+493419712705

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026